Clinical Trial Update: Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Tongxinluo Capsule for prevention and treatment of restenosis after intracranial and external arterial stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stent Restenosis

Drugs mentioned

• Tongxinluo Capsule

Snippet

Sponsor: Yanbin Li | Conditions: Stent Restenosis | Phase 4 | Status: NOT_YET_RECRUITING